| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -17,170 |
| Depreciation | 222 |
| Interest expense and amortization of debt discount on term loans (related party) | 1,586 |
| Stock-based compensation for services | 152 |
| Amortization of prepaid insurance | 738 |
| Stock-based compensation | 478 |
| Change in fair value of private warrant liability | 339 |
| Change in fair value of publicly traded warrant liability | -129 |
| Change in fair value of forward purchase agreement warrant liability | -522 |
| Change in operating lease right-of-use asset (related party) | -39 |
| Change in inventory reserve | 68 |
| Accounts receivable, net | -3 |
| Other receivable | -761 |
| Inventories | -1 |
| Prepaid expenses and other current assets | 74 |
| Accounts payable | 973 |
| Operating lease liability (related party) | 1 |
| Accrued expenses | 216 |
| Product warranty liability | -120 |
| Net cash used in operating activities | -12,516 |
| Purchases of property and equipment | 7 |
| Net cash used in investing activities | -7 |
| Payments on insurance financing loans | 636 |
| Proceeds from the issuance of term loans (related party) | 10,000 |
| Dividends paid to stockholders of series a preferred stock | 1,820 |
| Payment made for extinguishment of term loans (related party) | 100 |
| Proceeds from the issuance of common stock from atm offering | 414 |
| Proceeds from issuance of common stock under employee stock purchase plan | 77 |
| Proceeds from exercise of forward purchase agreement warrants | 158 |
| Proceeds from the issuance of common stock and investor warrants from registered direct offering | 2,500 |
| Net cash provided by financing activities | 10,593 |
| Effect of exchange rate changes on cash | 3 |
| Net (decrease) increase in cash | -1,927 |
| Cash and cash equivalents at beginning of period | 5,483 |
| Cash and cash equivalents at end of period | 3,556 |
Envoy Medical, Inc. (COCHW)
Envoy Medical, Inc. (COCHW)